Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - SCIVANTA MEDICAL CORP | f10q0411_scivanta.htm |
| EX-4.4 - 8% CONVERTIBLE DEBENTURE, DATED AS OF MAY 20, 2011 - SCIVANTA MEDICAL CORP | f10q0411ex4iv_scivanta.htm |
| EX-31.1 - CERTIFICATION - SCIVANTA MEDICAL CORP | f10q0411ex31i_scivanta.htm |
| EX-32.2 - CERTIFICATION - SCIVANTA MEDICAL CORP | f10q0411ex32ii_scivanta.htm |
| EX-31.2 - CERTIFICATION - SCIVANTA MEDICAL CORP | f10q0411ex31ii_scivanta.htm |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Scivanta Medical Corporation (the “Company”) on Form 10-Q for the period ended April 30, 2011, as filed with the Securities and Exchange Commission (the “Report”), I, David R. LaVance, President and Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) the Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, 15 U.S.C. §78m or 78o(d), and,
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 14, 2011
By: /s/ David R. LaVance
David R. LaVance
President and Chief Executive Officer